These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 34493762)

  • 41. Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures.
    Leuzinger K; Gosert R; Søgaard KK; Naegele K; Bielicki J; Roloff T; Bingisser R; Nickel CH; Khanna N; Sutter ST; Widmer AF; Rentsch K; Pargger H; Siegemund M; Stolz D; Tamm M; Bassetti S; Osthoff M; Battegay M; Egli A; Hirsch HH
    J Med Virol; 2021 Apr; 93(4):2374-2384. PubMed ID: 33314153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Timing the SARS-CoV-2 index case in Hubei province.
    Pekar J; Worobey M; Moshiri N; Scheffler K; Wertheim JO
    Science; 2021 Apr; 372(6540):412-417. PubMed ID: 33737402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surveillance for SARS-CoV-2 variants of concern in the Australian context.
    Andersson P; Sherry NL; Howden BP
    Med J Aust; 2021 Jun; 214(11):500-502.e1. PubMed ID: 34060079
    [No Abstract]   [Full Text] [Related]  

  • 44. Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.
    Rahman MS; Islam MR; Alam ASMRU; Islam I; Hoque MN; Akter S; Rahaman MM; Sultana M; Hossain MA
    J Med Virol; 2021 Apr; 93(4):2177-2195. PubMed ID: 33095454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of the reproduction number from coronavirus SARS-CoV-2 case data in Germany and implications for political measures.
    Khailaie S; Mitra T; Bandyopadhyay A; Schips M; Mascheroni P; Vanella P; Lange B; Binder SC; Meyer-Hermann M
    BMC Med; 2021 Jan; 19(1):32. PubMed ID: 33504336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative frequency of genomic mutations in SARS-CoV-2 recovered from southern Brazilian cases of COVID-19 through the Gamma, Delta and Omicron waves.
    Filippi M; Demoliner M; Gularte JS; de Abreu Goes Pereira VM; da Silva MS; Girardi V; Hansen AW; Spilki FR
    Infect Genet Evol; 2024 Jun; 120():105590. PubMed ID: 38574833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early Adoption of Longitudinal Surveillance for SARS-CoV-2 among Staff in Long-Term Care Facilities: Prevalence, Virologic and Sequence Analysis.
    Gallichotte EN; Quicke KM; Sexton NR; Fitzmeyer E; Young MC; Janich AJ; Dobos K; Pabilonia KL; Gahm G; Carlton EJ; Ebel GD; Ehrhart N
    Microbiol Spectr; 2021 Dec; 9(3):e0100321. PubMed ID: 34756092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of the mutation dynamics of SARS-CoV-2 genome in the samples from Georgia State of the United States.
    Ahmad W; Ahmad S; Basha R
    Gene; 2022 Oct; 841():146774. PubMed ID: 35905853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular epidemiology analysis of early variants of SARS-CoV-2 reveals the potential impact of mutations P504L and Y541C (NSP13) in the clinical COVID-19 outcomes.
    Cao C; He L; Tian Y; Qin Y; Sun H; Ding W; Gui L; Wu P
    Infect Genet Evol; 2021 Aug; 92():104831. PubMed ID: 33798758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic.
    Colson P; Chaudet H; Delerce J; Pontarotti P; Levasseur A; Fantini J; La Scola B; Devaux C; Raoult D
    J Infect; 2024 May; 88(5):106150. PubMed ID: 38570164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence.
    Kraemer MUG; Hill V; Ruis C; Dellicour S; Bajaj S; McCrone JT; Baele G; Parag KV; Battle AL; Gutierrez B; Jackson B; Colquhoun R; O'Toole Á; Klein B; Vespignani A; ; Volz E; Faria NR; Aanensen DM; Loman NJ; du Plessis L; Cauchemez S; Rambaut A; Scarpino SV; Pybus OG
    Science; 2021 Aug; 373(6557):889-895. PubMed ID: 34301854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What containment strategy leads us through the pandemic crisis? An empirical analysis of the measures against the COVID-19 pandemic.
    Kaimann D; Tanneberg I
    PLoS One; 2021; 16(6):e0253237. PubMed ID: 34153058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Updated picture of SARS-CoV-2 variants and mutations.
    Lippi G; Mattiuzzi C; Henry BM
    Diagnosis (Berl); 2021 Dec; 9(1):11-17. PubMed ID: 34958184
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.
    Saha O; Islam I; Shatadru RN; Rakhi NN; Hossain MS; Rahaman MM
    Virus Genes; 2021 Oct; 57(5):413-425. PubMed ID: 34251592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phylogenomics reveals multiple introductions and early spread of SARS-CoV-2 into Peru.
    Juscamayta-López E; Carhuaricra D; Tarazona D; Valdivia F; Rojas N; Maturrano L; Gavilán R
    J Med Virol; 2021 Oct; 93(10):5961-5968. PubMed ID: 34185310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2.
    Giovanetti M; Branda F; Cella E; Scarpa F; Bazzani L; Ciccozzi A; Slavov SN; Benvenuto D; Sanna D; Casu M; Santos LA; Lai A; Zehender G; Caccuri F; Ianni A; Caruso A; Maroutti A; Pascarella S; Borsetti A; Ciccozzi M
    J Med Virol; 2023 Aug; 95(8):e29012. PubMed ID: 37548148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.
    Benvenuto D; Demir AB; Giovanetti M; Bianchi M; Angeletti S; Pascarella S; Cauda R; Ciccozzi M; Cassone A
    J Med Virol; 2020 Oct; 92(10):2232-2237. PubMed ID: 32492183
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of Three Mutations in Italian Strains of SARS-CoV-2: Implications for Pathogenesis.
    Benvenuto D; Benedetti F; Demir AB; Ciccozzi M; Zella D
    Chemotherapy; 2021; 66(1-2):33-37. PubMed ID: 33735872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.